This work is licensed under the Creative Commons Attribution 4.0 International License.
Castellani C, Duf AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, et al. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros. 2018 Mar;17(2):153-178. doi: 10.1016/j.jcf.2018.02.006.CastellaniCDufAJABellSCHeijermanHGMMunckARatjenFet alECFS best practice guidelines: the 2018 revision2018Mar17215317810.1016/j.jcf.2018.02.00629506920Open DOISearch in Google Scholar
Sanders DB, Bittner RC, Rosenfeld M, Hofman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182(5):627-632. doi: 10.1164/rccm.200909-1421OC.SandersDBBittnerRCRosenfeldMHofmanLRReddingGJGossCHFailure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation2010182562763210.1164/rccm.200909-1421OC545076320463179Open DOISearch in Google Scholar
Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011;46(4):393-400. doi: 10.1002/ppul.21374.SandersDBBittnerRCRosenfeldMReddingGJGossCHPulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis201146439340010.1002/ppul.2137420967845Open DOISearch in Google Scholar
Collaco JM, Green DM, Cutting GR, Naughton KM, Mogayzel PJ Jr. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not afect outcomes. Am J Respir Crit Care Med. 2010;182(9):1137-1143. doi: 10.1164/rccm.201001-0057OC.CollacoJMGreenDMCuttingGRNaughtonKMMogayzelPJJrLocation and duration of treatment of cystic fibrosis respiratory exacerbations do not afect outcomes201018291137114310.1164/rccm.201001-0057OC300125620581166Open DOISearch in Google Scholar
VanDevanter DR, Pasta DJ, Konstan MW. Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis. J Cyst Fibros. 2015;14(6):763-769. doi: 10.1016/j. jcf.2015.02.007.VanDevanterDRPastaDJKonstanMWTreatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis201514676376910.1016/j.jcf.2015.02.007456103325754096Open DOISearch in Google Scholar
Stephenson AL, Tom M, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study. Eur Respir J. 2015;45(3):670-679. doi: 10.1183/09031936.00119714.StephensonALTomMBerthiaumeYSingerLGAaronSDWhitmoreGAStanojevicSA contemporary survival analysis of individuals with cystic fibrosis: a cohort study201545367067910.1183/09031936.0011971425395034Open DOISearch in Google Scholar
Stenbit AE, Flume PA. Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2011;17(6):442-447. doi: 10.1097/ MCP.0b013e32834b8c04.StenbitAEFlumePAPulmonary exacerbations in cystic fibrosis201117644244710.1097/MCP.0b013e32834b8c0421881509Open DOISearch in Google Scholar
Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180(9):802-808. doi: 10.1164/rccm.200812-1845PP.FlumePAMogayzelPJ JrRobinsonKAGossCHRosenblattRLKuhnRJMarshallBC.Clinical Practice Guidelines for Pulmonary Therapies Committee2009180980280810.1164/rccm.200812-1845PP19729669Open DOISearch in Google Scholar
Flume PA, Robinson KA, O’Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009;54(4):522-537.FlumePARobinsonKAO’SullivanBPFinderJDVenderRLWilley-CourandDBWhiteTBMarshallBC.Clinical Practice Guidelines for Pulmonary Therapies Committee2009544522537Search in Google Scholar
De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, Sinaasappel M; Diagnostic Working Group. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61(7):627-635. doi: 10.1136/thx.2005.043539.DeBoeck KWilschanskiMCastellaniCTaylorCCuppensHDodgeJSinaasappelMDiagnostic Working Group200661762763510.1136/thx.2005.043539210467616384879Open DOISearch in Google Scholar
Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4-S14. doi: 10.1016/j.jpeds.2008.05.005.FarrellPMRosensteinBJWhiteTBAccursoFJCastellaniCCuttingGRet alCystic Fibrosis Foundation20081532S4S1410.1016/j.jpeds.2008.05.005281095818639722Open DOISearch in Google Scholar
Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Efect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994;331(10):637-642. doi: 10.1056/NEJM199409083311003.FuchsHJBorowitzDSChristiansenDHMorrisEMNashMLRamseyBWRosensteinBJSmithALWohlMEEfect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis19943311063764210.1056/NEJM1994090833110037503821Open DOISearch in Google Scholar
Horsley A. Lung clearance index in the assessment of airways disease. Respir Med. 2009;103(6):793-799. doi: 10.1016/j. rmed.2009.01.025.HorsleyALung clearance index in the assessment of airways disease2009103679379910.1016/j.rmed.2009.01.02519246184Open DOISearch in Google Scholar
Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al.; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An oficial American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175(12):13041345. doi: 10.1164/rccm.200605-642ST.BeydonNDavisSDLombardiEAllenJLAretsHGAuroraPet alAmerican Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing2007175121304134510.1164/rccm.200605-642ST17545458Open DOISearch in Google Scholar
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. doi: 10.1183/09031936.05.00034805.MillerMRHankinsonJBrusascoVBurgosFCasaburiRCoatesAet alATS/ERS Task Force200526231933810.1183/09031936.05.0003480516055882Open DOISearch in Google Scholar
Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, et al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur Respir J. 2013;41(3):507-522. doi: 10.1183/09031936.00069712.RobinsonPDLatzinPVerbanckSHallGLHorsleyAGappaMet alConsensus statement for inert gas washout measurement using multiple- and single-breath tests201341350752210.1183/09031936.0006971223397305Open DOISearch in Google Scholar
Horsley A, Siddiqui S. Putting lung function and physiology into perspective: cystic fibrosis in adults. Respirology. 2015;20(1):3345. doi: 10.1111/resp.12382.HorsleyASiddiquiSPutting lung function and physiology into perspective: cystic fibrosis in adults2015201334510.1111/resp.1238225219816Open DOISearch in Google Scholar
Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax. 2008;63(2):129-134. doi: 10.1136/thx.2007.077784.GustafssonPMDeJong PATiddensHALindbladA.Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis200863212913410.1136/thx.2007.07778417675316Open DOISearch in Google Scholar
Graeber SY, Dopfer C, Naehrlich L, Gyulumyan L, Scheuermann H, Hirtz S, et al. Efects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis. Am J Respir Crit Care Med. 2018;197(11):1433-1442. doi: 10.1164/ rccm.201710-1983OC.GraeberSYDopferCNaehrlichLGyulumyanLScheuermannHHirtzSet alEfects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis2018197111433144210.1164/rccm.201710-1983OC29327948Open DOISearch in Google Scholar
Eckrich J, Zissler UM, Serve F, Leutz P, Smaczny C, Schmitt-Grohé S et al. Airway inflammation in mild cystic fibrosis. J Cyst Fibros. 2017;16(1):107-115. doi: 10.1016/j.jcf.2016.05.016.EckrichJZisslerUMServeFLeutzPSmacznyCSchmitt-GrohéSet alAirway inflammation in mild cystic fibrosis201716110711510.1016/j.jcf.2016.05.01627296563Open DOISearch in Google Scholar
Loeve M, Rosenow T, Gorbunova V, Hop WC, Tiddens HA, de Bruijne M. Reversibility of trapped air on chest computed tomography in cystic fibrosis patients. Eur J Radiol. 2015;84(6):11841190. doi: 10.1016/j.ejrad.2015.02.011.LoeveMRosenowTGorbunovaVHopWCTiddensHAdeBruijne M.Reversibility of trapped air on chest computed tomography in cystic fibrosis patients20158461184119010.1016/j.ejrad.2015.02.01125840703Open DOISearch in Google Scholar
van der Giessen LJ, de Jongste JC, Gosselink R, Hop WC, Tiddens HA. RhDNase before airway clearance therapy improves airway patency in children with CF. Pediatr Pulmonol. 2007;42(7):624-630. doi: 10.1002/ppul.20636.vander Giessen LJdeJongste JCGosselinkRHopWCTiddensHARhDNase before airway clearance therapy improves airway patency in children with CF200742762463010.1002/ppul.2063617534979Open DOISearch in Google Scholar
Rosenfeld M, VanDevanter DR, Ren CL, Elkin EP, Pasta DJ, Konstan MW, Morgan WJ; Investigators of Coordinators of the Epidemiologic Study of Cystic Fibrosis. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients. Pediatr Pulmonol. 2015;50(9):856-862. doi: 10.1002/ ppul.23227.RosenfeldMVanDevanterDRRenCLElkinEPPastaDJKonstanMWMorganWJ.Investigators of Coordinators of the Epidemiologic Study of Cystic Fibrosis201550985686210.1002/ppul.2322726086901Open DOISearch in Google Scholar
Bakker EM, Borsboom GJ, van der Wiel-Kooij EC, Caudri D, Rosenfeld M, Tiddens HA. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker. Pediatr Pulmonol. 2013;48(11):1081-1088. doi: 10.1002/ppul.22777.BakkerEMBorsboomGJvander Wiel-Kooij ECCaudriDRosenfeldMTiddensHA.Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker201348111081108810.1002/ppul.2277723401260Open DOISearch in Google Scholar
Verbanck S, Paiva M, Schuermans D, Hanon S, Vincken W, Van Muylem A. Relationships between the lung clearance index and conductive and acinar ventilation heterogeneity. J Appl Physiol (1985). 2012;112(5):782-790. doi: 10.1152/japplphysiol.01221.2011.VerbanckSPaivaMSchuermansDHanonSVinckenWVanMuylem ARelationships between the lung clearance index and conductive and acinar ventilation heterogeneity2012112578279010.1152/japplphysiol.01221.201122162528Open DOISearch in Google Scholar
Vermeulen F, Proesmans M, Boon M, Havermans T, De Boeck K. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax. 2014;69(1):39-45. doi: 10.1136/thoraxjnl-2013-203807.VermeulenFProesmansMBoonMHavermansTDeBoeck K.Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis2014691394510.1136/thoraxjnl-2013-20380724021874Open DOISearch in Google Scholar
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis. Thorax. 2018;73(5):451-458. doi: 10.1136/thoraxjnl-2017-210979.RaymentJHStanojevicSDavisSDRetsch-BogartGRatjenFLung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis201873545145810.1136/thoraxjnl-2017-21097929449440Open DOISearch in Google Scholar
Stanojevic S, Davis SD, Retsch-Bogart G, Webster H, Davis M, Johnson RC, et al. Progression of Lung Disease in Preschool Patients with Cystic Fibrosis. Am J Respir Crit Care Med. 2017;195(9):1216-1225. doi: 10.1164/rccm.201610-2158OC.StanojevicSDavisSDRetsch-BogartGWebsterHDavisMJohnsonRCet alProgression of Lung Disease in Preschool Patients with Cystic Fibrosis201719591216122510.1164/rccm.201610-2158OC543901827943680Open DOISearch in Google Scholar
Welsh L, Nesci C, Tran H, Tomai M, Ranganathan S. Lung clearance index during hospital admission in school-age children with cystic fibrosis. J Cyst Fibros. 2014;13(6):687-691. doi: 10.1016/j.jcf.2014.05.012.WelshLNesciCTranHTomaiMRanganathanSLung clearance index during hospital admission in school-age children with cystic fibrosis201413668769110.1016/j.jcf.2014.05.01224917113Open DOISearch in Google Scholar
Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, Aziz ZA, et al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax. 2013;68(6):532-539. doi: 10.1136/ thoraxjnl-2012-202538.HorsleyARDaviesJCGrayRDMacleodKADonovanJAzizZAet alChanges in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation201368653253910.1136/thoraxjnl-2012-20253823396354Open DOISearch in Google Scholar
Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol. 2009;44(8):733-742. doi: 10.1002/ppul.20956.RobinsonPDCooperPVanAsperen PFitzgeraldDSelvaduraiH.Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis200944873374210.1002/ppul.2095619598271Open DOISearch in Google Scholar
Sonneveld N, Stanojevic S, Amin R, Aurora P, Davies J, Elborn JS, Horsley A, Latzin P, O’Neill K, Robinson P, Scrase E, Selvadurai H, Subbarao P, Welsh L, Yammine S, Ratjen F. Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations. Eur Respir J. 2015;46(4):1055-1064. doi: 10.1183/09031936.00211914.SonneveldNStanojevicSAminRAuroraPDaviesJElbornJSHorsleyALatzinPO’NeillKRobinsonPScraseESelvaduraiHSubbaraoPWelshLYammineSRatjenFLung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations20154641055106410.1183/09031936.0021191426160868Open DOISearch in Google Scholar
Yammine S, Bigler A, Casaulta C, Singer F, Latzin P. Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Thorax. 2014;69(2):183. doi: 10.1136/ thoraxjnl-2013-204283.YammineSBiglerACasaultaCSingerFLatzinPReasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment201469218310.1136/thoraxjnl-2013-20428323988751Open DOISearch in Google Scholar
Rowan SA, Bradley JM, Bradbury I, Lawson J, Lynch T, Gustafsson P, et al. Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med. 2014;189(5):586-592. doi: 10.1164/ rccm.201310-1747OC.RowanSABradleyJMBradburyILawsonJLynchTGustafssonPet alLung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis2014189558659210.1164/rccm.201310-1747OC24428575Open DOISearch in Google Scholar
Caskey S, Gough A, Rowan S, Gillespie S, Clarke J, Riley M, et al. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2016;13(8):1262-1270. doi: 10.1513/AnnalsATS.201509-578OC.CaskeySGoughARowanSGillespieSClarkeJRileyMet alStructural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia20161381262127010.1513/AnnalsATS.201509-578OC27222921Open DOISearch in Google Scholar
Gustafsson PM. Peripheral airway involvement in CF and asthma compared by inert gas washout. Pediatr Pulmonol. 2007;42(2):168-176. doi: 10.1002/ppul.20554.GustafssonPMPeripheral airway involvement in CF and asthma compared by inert gas washout200742216817610.1002/ppul.2055417186546Open DOISearch in Google Scholar
Sonnappa S, Bastardo CM, Wade A, Bush A, Stocks J, Aurora P. Repeatability and bronchodilator reversibility of lung function in young children. Eur Respir J. 2013;42(1):116-124. doi: 10.1183/09031936.00076012.SonnappaSBastardoCMWadeABushAStocksJAuroraPRepeatability and bronchodilator reversibility of lung function in young children201342111612410.1183/09031936.0007601223222876Open DOISearch in Google Scholar
Fuchs SI, Toussaint S, Edlhaimb B, Ballmann M, Gappa M. Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol. 2010;45(3):301-306. doi: 10.1002/ppul.21180.FuchsSIToussaintSEdlhaimbBBallmannMGappaMShort-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis201045330130610.1002/ppul.2118020146388Open DOISearch in Google Scholar
Pfleger A, Steinbacher M, Schwantzer G, Weinhandl E, Wagner M, Eber E. Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with a wide range of lung disease severity. J Cyst Fibros. 2015;14(5):627-631. doi: 10.1016/j.jcf.2014.12.017.PflegerASteinbacherMSchwantzerGWeinhandlEWagnerMEberEShort-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with a wide range of lung disease severity201514562763110.1016/j.jcf.2014.12.01725612899Open DOISearch in Google Scholar
Marques A, Cruz J, Jácome C, Oliveira A. Outcome measures for respiratory physiotherapy in cystic fibrosis - challenges and advances. online book chapter]. s. 37-71. doi: 10.5772/60674. IN: Cystic fibrosis in the light of new research. Ed. by Wat D. London, UK : IntechOpen Limited, 2015. doi: 10.5772/59523. ISBN 978-953-51-2152-7, eBook ISBN 978-953-51-7248-2. Available from: https://www.intechopen.com/books/cystic-fibrosis-in-the-light-of-new-research/outcome-measures-for-respiratory-physiotherapy-in-cystic-fibrosis-challenges-and-advances (accessed 5 Jun 2019).MarquesACruzJJácomeCOliveiraAOutcome measures for respiratory physiotherapy in cystic fibrosis - challenges and advancess37–7110.5772/60674IN: Cystic fibrosis in the light of new research. Ed. by Wat D. London, UK : IntechOpen Limited, 2015. 10.5772/59523. ISBN 978-953-51-2152-7, eBook ISBN 978-953-51-7248-2. Available fromhttps://www.intechopen.com/books/cystic-fibrosis-in-the-light-of-new-research/outcome-measures-for-respiratory-physiotherapy-in-cystic-fibrosis-challenges-and-advances(accessed 5 Jun 2019)Open DOISearch in Google Scholar